COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Covid Alert


Print ISSN:-2394-6784

Online ISSN:-2394-6792

CODEN : IJPOF3

Current Issue

Year 2020

Volume: 7 , Issue: 2

Article Access statistics

Viewed: 512

Emailed: 0

PDF Downloaded: 220

Indian Journal of Pathology and Oncology


Proliferative fasciitis, a rare pseudosarcoma


Full Text PDF Share on Facebook Share on Twitter


Author Details : Ajitha Porkodi KV, Thanka Johnson, Rajendiran Swaminathan, Susruthan Muralitharan, Lawrence D Cruze

Volume : 5, Issue : 3, Year : 2018

Article Page : 509-511


Suggest article by email


Abstract

Of the many benign mimickers of soft tissue sarcoma, proliferative fasciitis is a rare entity which is a diagnostic challenge for pathologist. Recognition of this pseudo sarcoma is very essential as it aids in the appropriate management of the same. Other members of the pseudo sarcoma family are proliferative myositis, nodular fasciitis, inflammatory pseudotumor and proliferative peribursitis. We present 3 cases of proliferative fasciitis which was reported in our hospital in the last 10 years, between 2007 and 2017.

Keywords: Pseudosarcoma, Proliferative fasciitis, Rare soft tissue pseudo sarcoma.

Doi : 10.18231/2394-6792.2018.0098

How to cite : Ajitha Porkodi Kv, Johnson T, Swaminathan R, Muralitharan S, Cruze L D, Proliferative fasciitis, a rare pseudosarcoma. Indian J Pathol Oncol 2018;5(3):509-511

Copyright © 2018 by author(s) and Indian J Pathol Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)